294 related articles for article (PubMed ID: 30257068)
1. Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa.
Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Danel C; Delaugerre C; Zoulim F; Lacombe K;
Liver Int; 2019 Feb; 39(2):280-289. PubMed ID: 30257068
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
3. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
[TBL] [Abstract][Full Text] [Related]
4. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
[TBL] [Abstract][Full Text] [Related]
6. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
Coffin CS; Osiowy C; Myers RP; Gill MJ
J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa.
Boyd A; Kouamé MG; Houghtaling L; Moh R; Gabillard D; Maylin S; Abdou Chekaraou M; Delaugerre C; Anglaret X; Eholié SP; Danel C; Zoulim F; Lacombe K;
Trans R Soc Trop Med Hyg; 2019 Aug; 113(8):437-445. PubMed ID: 31574151
[TBL] [Abstract][Full Text] [Related]
8. Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.
Boyd A; Maylin S; Gozlan J; Delaugerre C; Simon F; Girard PM; Lacombe K
Liver Int; 2015 Mar; 35(3):795-804. PubMed ID: 24606220
[TBL] [Abstract][Full Text] [Related]
9. Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
Yang R; Gui X; Ke H; Xiong Y; Gao S
J Viral Hepat; 2020 Feb; 27(2):127-134. PubMed ID: 31571343
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
[TBL] [Abstract][Full Text] [Related]
11. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
12. Quantitative hepatitis B surface antigen titres in Chinese chronic hepatitis B patients over 4 years of entecavir treatment.
Chen EQ; Wang TT; Bai L; Tao CM; Liang T; Liu C; Liao J; Tang H
Antivir Ther; 2013; 18(8):955-65. PubMed ID: 23639885
[TBL] [Abstract][Full Text] [Related]
13. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
[TBL] [Abstract][Full Text] [Related]
15. Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India.
Saha D; Pal A; Biswas A; Panigrahi R; Sarkar N; Sarkar J; Pal M; Guha SK; Saha B; Chakrabarti S; Chakravarty R
PLoS One; 2013; 8(8):e73613. PubMed ID: 24023688
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
[TBL] [Abstract][Full Text] [Related]
17. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
Matthews GV; Ali RJ; Avihingsanon A; Amin J; Hammond R; Bowden S; Lewin SR; Sasadeusz J; Littlejohn M; Locarnini SL; Ruxrungtham K; Dore GJ
PLoS One; 2013; 8(4):e61297. PubMed ID: 23593455
[TBL] [Abstract][Full Text] [Related]
18. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
Hawkins C; Kang M; Bhattacharya D; Cloherty G; Kuhns M; Matining R; Thio C; Samaneka W; Chinula L; Mulinda N; Badal-Faesen S; Sugandhavesa P; Lama J; Gaseitsiwe S; Holzmayer V; Anderson M; Murphy R; Peters M
AIDS; 2022 Jun; 36(7):975-984. PubMed ID: 35165216
[TBL] [Abstract][Full Text] [Related]
20. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
